I raised yesterday whether Macquarie might be the lead broker if the TH was indeed in relation to a capital raising.
I originally had the thought that it was plausible that Macquarie have downweighted NMS over the last couple of months at a higher price than what it may expect to pick up additional stock atin a rights issue or institutional share placement now?
However from today's lodgement it appears most of the trades occurred in the 40s.
Also looks like many of the trades through April were actually units bought via off market transfer...? Perhaps flushing tax pre 30 June? Confusing as to what Macquarie's plan is.
All in all they still hold 12% of the company and as at most recent update Macquarie Small Companies Fund holds 7.26% (slightly lower now) of the portfolio in Neptune.
The next largest holding is HALF that size being Healthscope at 3.51% of the portfolio.
NMS Price at posting:
59.0¢ Sentiment: LT Buy Disclosure: Held
